Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative

Archives of Ophthalmology

Volumn 114, Issue 2, 1996, Pages 186-192

  Young, Lucy H Y ^a,b   Howard, Martha A ^a   Hu, Li Kuan ^a   Kim, Rosa Y ^a   Gragoudas, Evangelos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CYCLOSPORIN; CYCLOSPORIN A; LIPOSOME;

ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; CANCER INHIBITION; CHOROID MELANOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT;

EID: 0030020494     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130180013     Document Type: Article

References (48)

1. Prout GR Jr, Lin CW, Benson R Jr, et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med. 1987:317:1251-1255
2. Karanov S, Kostadinov D, Shopova M, Durtev P. Photodynamic therapy in lung and gastrointestinal cancers. J Photochem Photobiol B. 1990;6:175-181.
3. Bruce RA Jr. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas. Lasers Surg Med. 1984;4:59-64.
4. Tse DT, Dutton JJ, Weingeis TA, et al. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol. 1984;102: 833-838.
5. Sery TW, Shield JA, Augsburger JJ, Shah HG. Photodynamic therapy of human ocular cancer. Ophthalmic Surg. 1987;18.413-418
6. Murphree AL, Cote M, Gomer CJ. The evolution of photodynamic therapy techniques in the treatment of intraocular tumors. Photochem Photobiol. 1987;46: 919-923.
7. Kessel D, Chang CK, Musselman B. Chemical, biologic and biophysical studies on hematoporphyrin derivative In Kessel D, ed. Methods in Porphyrin Photosensitization. New York, NY: Plenum Publishing Corp; 1985:213-217
8. Spikes JD. Photobiology of porphyrins In. Doiron DR, Gomer CJ, eds. Porphyrin Localization and Treatment of Tumors New York: Alan R Liss Inc; 1984: 19-39
9. Panagopoulos JA, Svitra PD, Puliafito CA, Gragoudas ES. Photodynamic therapy for experimental intraocular melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol. 1989;107:886-890
10. Ozler SA, Nelson SJ, Liggett PE, et al Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine. Arch Ophthalmol 1992:110.555-561
11. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 1994;101 89-99
12. Hu LK, Huh K, Gragoudas ES, Young LHY Establishment of pigmented choroidal melanomas in a rabbit model. Retina. 1994,14:264-269.
13. Richter AM, Kelly B, Chow J, et al Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Natl Cancer Inst 1987;79 1327-1332
14. 3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice J Photochem Photobiol B 1990,5.231-244.
15. Lui J, Hruza L, Kollias N, et al Photodynamic therapy of malignant skin tumors with benzoporphyrin derivative-monoacid ring A (BPD-MA): preliminary investigations. In. Proceedings of the Lasers in Otolaryngology, Dermatology, and Tissue Welding Bellingham, Wash Society of Photo-Optical Instrumentation Engineers; 1993;1876:147-151.
16. Buchanan RB, Carruth HAS, McKenzie AL, Williams SR. Photodynamic therapy in the treatment of malignant tumors of the skin and head and neck. Eur J Surg Oncol. 1989;15 400-406.
17. McCaughn JS Jr Photodynamic therapy of skin and esophageal cancers Cancer Invest. 1990;83:407-416.
18. Wening BL, Kurtzman DM, Grossweiner LI, et al. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1990;116:1267-1270.
19. Richter AM, Waterfield E, Jain AK, et al. Photosensitizing potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumor model Br J Cancer. 1991;63:87-93.
20. Bernstein EF, Thomas GF, Smith PD, et al. Response of black and white guinea pig skin to photodynamic treatment using 514-nm light and dihematoporphyrin ether. Arch Dermatol. 1990,126:1303-1307.
21. Svaasand LO, Ellingsen N Optical properties of human brain Photochem Photobiol. 1983;38:293-299.
22. Svaasand LO, Morinelli E, Gomer CJ, Profio AE. Optical characteristics of intraocular tumors in the visible and near infrared. Soc Photo-Optical Instrum Eng 1990;1203:2-11
23. Bachor R, Shea CR. Gillies R, Hasan T. Photosensitized destruction of human bladder carcinoma cells treated with chlorine 6-conjugated microspheres. Proc Natl Acad Sci U S A 1991;88:1580-1584.
24. Hasan T. Photosensitizer delivery mediated by macromolecular carrier systems In: Henderson BW, Dougherty TJ, eds Photodynamic Therapy: Basic Principles and Clinical Applications. New York. NY: Marcel Dekker Inc, 1992 187-199.
25. Jori G Low-density lipoproteins-liposome delivery systems for tumor photosensitizers in vivo. In: Henderson BW, Dougherty TJ, eds. Photodynamic Therapy Basic Principles and Clinical Applications. New York, NY: Marcel Dekker Inc; 1992:173-185.
26. Mew D, Wat CK, Tower GHN, et al. Photoimmunotherapy treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol. 1983, 130:1473-1477.
27. Allison BA, Waterfield E, Richter AM, Levy JG. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991;54:709-715.
28. Richter AM, Waterfield E, Jain AK, et al Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model Photochem Photobiol 1993;57:1000-1006
29. Rutledge JC, Curry F-RE, Lenz JF, Davis PA. Low-density lipoprotein transport across a microvascular endothelial barrier after permeability is increased. Circ Res. 1990;66:486-495.
30. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995;113.810-818.
31. Nelson JS, Liaw LH, Berns MW. Tumor destruction in photodynamic therapy. Photochem Photobiol. 1987;46:829-835
32. Franken NAD, Vrensen GFJM, Van Delft JL, et al Early morphological changes induced by photodynamic therapy in amelanotic Greene melanoma implanted in the anterior chamber of rabbits. Lasers Med Sci. 1988;3.27-34.
33. Milanesi C, Biolo R, Reddi E, et al. Ultrastructural studies on the mechanism of the photodynamic therapy of tumors. Photochem Photobiol 1987,46:675-681.
34. Berns MW, Coffey J, Wile AG. Laser photoradiation therapy of cancer: possible role of hyperthermia. Lasers Surg Med. 1984;4:87-92.
35. Svaasand LO. Photodynamic and photohyperthermic response of malignant tumors. Med Phys. 1985;12.455-461.
36. Kinsey JH, Cortese DA, Neel HB Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy. Cancer Res. 1983;43. 1562-1567
37. Mattiello, Hetzel F, Vandenheede L. Intratumor temperature measurements during photodynamic therapy. Photochem Photobiol. 1987;48:873-879
38. Finger PT, Packer S, Svitra PP, et al Thermoradiotherapy for intraocular tumors. Arch Ophthalmol. 1985, 69 854-860.
39. Riedel KG, Svitra PP, Seddon JM, et al. Proton beam irradiation and hyperthermia effects on experimental choroidal melanoma Arch Ophthalmol. 1985: 103:1862-1869.
40. Coleman DJ, Lizzi FL, Burgess SEP, et al Ultrasonic hyperthermia and radiation in the management of intraocular malignant melanoma. Am J Ophthalmol 1986;101 635-642
41. Mieler WF, Jaffe GJ, Steeves RA Ferromagnetic hyperthermia and iodine I 125 brachytherapy in the treatment of choroidal melanoma in a rabbit model Arch Ophthalmol. 1989;107 1524-1528.
42. Kimel S, Svaasand LO, Hammer-Wilson M, et al. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chonoallantoic membrane model lasers Surg Med. 1992;12 432-440.
43. Glassberg E, Lewandowski L, Halcin C, et al. Hyperthermia potentiates the effects of aluminum phthalocyanine tetrasulfonate-mediated photodynamic toxicity in human malignant and normal cell lines. Lasers Surg Med. 1991;11. 432-439.
44. Gomer JC, Doiron RD, White L, et al. Hematoporphyrin derivative photoradiation-induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res 1984;3:229-237.
45. Gonzalez VH, Hu LK, Theodossiadis PG, et al. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci. 1995;36 871-878
46. Seddon JM, Gragoudas ES, Polivogianis L, et al Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology. 1986;93:666-674.
47. Seddon JM, Gragoudas ES, Egan KM. et al. Uveal melanomas near the optic disc or fovea visual results after proton beam irradiation Ophthalmology. 1987 94:354-361.
48. Cruess AF, Augsburger JJ, Shields JA, et al. Visual results following cobalt plaque radiotherapy for posterior uveal melanomas Ophthalmology. 1984;91 131-136